Adaptilens, Inc. is an ophthalmic medical device company headquartered near Boston, Massachusetts, focused on developing advanced accommodating intraocular lenses (IOLs). Founded by ophthalmic device inventors, the company aims to restore natural range of vision for cataract patients through innovative lens technologies. It conducts clinical evaluations and secures venture backing to advance its medical device pipeline.
Subscribe to see ADAPTILENS, LLC’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
ADAPTILENS, LLC is a therapeutic devices company headquartered in Chestnut Hill, United States. Its most recent funding round raised $7M in April 2024. Xcout tracks 11 named people at ADAPTILENS, LLC, including Daniel Stanley (Chief Operating Officer).
As of 16 November 2026. Source: Xcout Intel.
5 more named people on record for ADAPTILENS, LLC, with roles, board committees and tenure — see the full roster →
Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| SEC Form D filing | $7M | — | |
| Seed | $17.5M | 8 named | |
| SEC Form D filing | $1.6M | — | |
| Seed | $1.6M | 6 named |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
A funding-flow diagram of the 7 named investors across 2 rounds: who backed which round, who led it, and who came back for the next one.
Sign in to see it, or subscribe for the full funding history →
A few of ADAPTILENS, LLC's closest competitors — see the full list of competitors and alternatives →
Lentechs is a clinical-stage ophthalmic medical device company that develops patented soft, suspended contact lenses designed for individuals with presbyopia. Its technology is engineered to be suspended behind the upper eyelid to allow free eye movement behind a rotationally-stable lens, providing vision correction at multiple distances.
TECLens, Inc. is a company that develops a non-invasive, comfortable, and in-office vision correction procedure. Based in Connecticut, the firm has received equity funding to support its innovative medical treatments.
Omega Ophthalmics LLC develops the Gemini Capsule, an investigational medical implant designed to keep the capsular bag open and provide a stable position for intraocular lenses following cataract removal. The company serves the ophthalmic medical and business sectors by offering solutions to address post-operative capsular contraction.
Intelon Optics, Inc. is a medical device company headquartered in Lexington, Massachusetts. The firm focuses on the development and commercialization of advanced ophthalmic technology, specifically the Brillouin Optical Scanner System.
Ocumetics Technology Corp. is an innovation-driven enterprise specializing in the development and production of diverse optical lenses. One of its key innovations is the Bionic Lens, an expandable intraocular lens crafted to be implanted within the eye's natural lens compartment, offering a solution that eliminates the need for external vision correction. The company maintains its corporate headquarters in Calgary, Canada.
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Something wrong or missing about ADAPTILENS, LLC? Suggest a correction · Work at ADAPTILENS, LLC? Claim this profile
Post the link and the card appears automatically — each network fetches the image itself.